Adjuvance Overview
- Year Founded
-
2009
- Status
-
Out of Business
- Employees
-
18
- Latest Deal Type
-
Out of Business
Adjuvance General Information
Description
Developer of a biopharmaceutical platform designed to improve health and save lives through the development of vaccine adjuvant. The company's platform is based on saponex products that are critical components to many vaccines for multiple indications in infectious disease, oncology, neurobiology, substance abuse, and allergy, enabling patients to improve their immune systems.
Contact Information
Website
www.adjuvancetechnologies.comCorporate Office
- 1225 L Street
- Suite 600
- Lincoln, NE 68508
- United States
Corporate Office
- 1225 L Street
- Suite 600
- Lincoln, NE 68508
- United States
Adjuvance Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Out of Business | 25-Apr-2026 | Completed | Out of Business | |||
| 7. Grant | 19-May-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series A1) | 29-Jan-2020 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 4. Grant | 16-Jun-2019 | Completed | Pre-Clinical Trials | |||
| 3. Grant | 01-Mar-2017 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 01-Jan-2017 | $448K | $2.72M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 14-Nov-2016 | $2.72M | $2.72M | Completed | Pre-Clinical Trials |
Adjuvance Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-2 |
Adjuvance Comparisons
Industry
Financing
Details
Adjuvance Competitors (3)
One of Adjuvance’s 3 competitors is Dynavax Technologies, a Formerly VC-backed company based in Emeryville, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dynavax Technologies | Formerly VC-backed | Emeryville, CA | ||||
| Novavax | Corporation | Gaithersburg, MD | ||||
| Glaxosmithkline Biologicals | Corporation | Saint-Amand-Les-Eaux, France |
Adjuvance Patents
Adjuvance Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4429674-A1 | Adjuvant compounds and formulations | Pending | 08-Nov-2021 | ||
| EP-4429674-A4 | Adjuvant compounds and formulations | Pending | 08-Nov-2021 | ||
| US-20250025550-A1 | Adjuvant compounds and formulations | Pending | 08-Nov-2021 | ||
| WO-2023081505-A1 | Adjuvant compounds and formulations | Inactive | 08-Nov-2021 | ||
| EP-4323377-A1 | Vaccines | Pending | 14-Apr-2021 | A61K39/39 |
Adjuvance Signals
Adjuvance FAQs
-
When was Adjuvance founded?
Adjuvance was founded in 2009.
-
Where is Adjuvance headquartered?
Adjuvance is headquartered in Lincoln, NE.
-
What is the size of Adjuvance?
Adjuvance has 18 total employees.
-
What industry is Adjuvance in?
Adjuvance’s primary industry is Drug Discovery.
-
Is Adjuvance a private or public company?
Adjuvance is a Private company.
-
What is Adjuvance’s current revenue?
The current revenue for Adjuvance is .
-
How much funding has Adjuvance raised over time?
Adjuvance has raised $22.7M.
-
Who are Adjuvance’s competitors?
Dynavax Technologies, Novavax, and Glaxosmithkline Biologicals are competitors of Adjuvance.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process